Device regulation used to be relatively simple. Not anymore. As increasingly complex products hit the market combining drugs, devices and biologics, the U.S. Food and Drug Administration has been required to decide whether a particular product is truly a device under the jurisprudence of the Center for Devices and Radiological Health, or whether it is a drug or other combination product that should follow a non-CDRH regulatory pathway.
